Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001231919-26-000186 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 21, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
14,500
Total Value
$0.00
P&L
+inf% (+$349,015.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 19, 2026 | Grant/Award | 6,200 | $0.00 | $0.00 | 6,200 | Indirect | See footnotes | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 19, 2026 | Grant/Award | 8,300 | $0.00 | $0.00 | 8,300 | Indirect | See Footnote | View Details |